“…Several studies have reported positivity of tumor cells with CD34 antibody in almost 100% of cases, and with CD99 antibody in 70% of cases, whereas Bcl-2, SMA, and epithelial membrane antigen are positive in 20% to 35% of the cases. Vimentin is positive in 90% of the cases, but is considered nonspecific [7,8]. …”